Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-01-26 Purchase | 2021-01-26 4:05 pm | Eidos Therapeutics Inc. | EIDX | BridgeBio Pharma Inc. 10% Owner | 14,428,836 | $0 | $0 | 1,000 (Direct) | View |
| 2021-01-13 Sale | 2021-01-15 4:05 pm | Eidos Therapeutics Inc. | EIDX | Sinha Uma Chief Scientific Officer | 10,000 | $124.32 | $1,243,179 | 306,525 (Direct) | View |
| 2021-01-11 Sale | 2021-01-13 4:05 pm | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 3,247 | $125.52 | $407,560 | 50,447 (Direct) | View |
| 2020-12-15 Sale | 2020-12-16 7:27 pm | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 26,294 | $111.77 | $2,938,796 | 113,247 (Direct) | View |
| 2020-12-02 Sale | 2020-12-04 5:34 pm | Eidos Therapeutics Inc. | EIDX | Sinha Uma Chief Scientific Officer | 5,000 | $90.04 | $450,187 | 316,525 (Direct) | View |
| 2020-11-11 Sale | 2020-11-13 5:00 pm | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 13,410 | $74.51 | $999,227 | 50,621 (Direct) | View |
| 2020-11-09 Sale | 2020-11-10 4:05 pm | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 1,623 | $74.93 | $121,609 | 27,597 (Direct) | View |
| 2020-11-02 Sale | 2020-11-03 4:05 pm | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 12,500 | $70.72 | $883,954 | 154,451 (Direct) | View |
| 2020-10-29 Sale | 2020-10-30 4:55 pm | Eidos Therapeutics Inc. | EIDX | Sinha Uma Chief Scientific Officer | 5,000 | $72.42 | $362,099 | 321,525 (Direct) | View |
| 2020-10-07 Sale | 2020-10-09 5:23 pm | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 10,643 | $74.97 | $797,899 | 63,639 (Direct) | View |
| 2020-09-30 Sale | 2020-10-02 7:43 pm | Eidos Therapeutics Inc. | EIDX | Sinha Uma Chief Scientific Officer | 5,000 | $52.34 | $261,717 | 326,525 (Direct) | View |
| 2020-09-17 Sale | 2020-09-18 4:06 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 5,767 | $50.16 | $289,259 | 380,967 (Indirect Direct) | View |
| 2020-09-14 Sale | 2020-09-16 6:35 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 4,233 | $50.14 | $212,224 | 386,734 (Indirect Direct) | View |
| 2020-09-10 Sale | 2020-09-11 4:05 pm | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 2,500 | $47 | $117,500 | 86,951 (Direct) | View |
| 2020-08-03 Sale | 2020-08-05 7:45 pm | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 10,000 | $39.94 | $399,450 | 150,531 (Direct) | View |
| 2020-07-07 Sale | 2020-07-09 4:05 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 5,000 | $50 | $250,000 | 390,967 (Indirect Direct) | View |
| 2020-06-03 Sale | 2020-06-05 4:06 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 5,000 | $50 | $250,000 | 394,879 (Indirect Direct) | View |
| 2020-05-28 Sale | 2020-06-01 4:05 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 5,000 | $50 | $250,000 | 401,475 (Indirect Direct) | View |
| 2020-05-26 Sale | 2020-05-28 4:05 pm | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 2,500 | $47 | $117,500 | 94,075 (Direct) | View |
| 2020-05-01 Sale | 2020-05-05 4:26 pm | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 10,000 | $40.84 | $408,433 | 160,155 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-12-28 Gift | 2021-01-28 7:50 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 500 | $0 | 0 (Direct) | View |
| 2021-01-26 Equity Swap | 2021-01-28 7:50 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 380,467 | $0 | 0 (Direct) | View |
| 2021-01-26 Disposition | 2021-01-28 7:50 pm | N/A 2028-11-05 | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 70,000 | $0 | 0 (Direct) | View |
| 2021-01-26 Disposition | 2021-01-28 7:39 pm | N/A 2030-08-05 | Eidos Therapeutics Inc. | EIDX | Rohlen Douglas Director | 25,973 | $0 | 0 (Direct) | View |
| 2021-01-26 Disposition | 2021-01-28 7:22 pm | N/A 2028-05-06 | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 24,350 | $0 | 0 (Direct) | View |
| 2021-01-26 Equity Swap | 2021-01-28 7:15 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 50,699 | $0 | 0 (Direct) | View |
| 2021-01-26 Disposition | 2021-01-28 7:15 pm | N/A 2028-06-20 | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 62,626 | $0 | 0 (Direct) | View |
| 2021-01-26 Disposition | 2021-01-28 7:08 pm | N/A 2030-05-27 | Eidos Therapeutics Inc. | EIDX | Satvat Ali J. Director | 86,112 | $0 | 0 (Direct) | View |
| 2021-01-26 Disposition | 2021-01-28 7:06 pm | N/A 2030-05-27 | Eidos Therapeutics Inc. | EIDX | Lis William Director | 86,112 | $0 | 0 (Direct) | View |
| 2021-01-26 Disposition | 2021-01-28 7:04 pm | N/A 2030-08-05 | Eidos Therapeutics Inc. | EIDX | Hooper Suzanne Sawochka Director | 25,973 | $0 | 0 (Direct) | View |
| 2020-10-27 Gift | 2021-01-28 7:00 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Sinha Uma Chief Scientific Officer | 3,000 | $0 | 0 (Direct) | View |
| 2021-01-26 Equity Swap | 2021-01-28 7:00 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Sinha Uma Chief Scientific Officer | 303,525 | $0 | 0 (Direct) | View |
| 2021-01-26 Disposition | 2021-01-28 7:00 pm | N/A 2028-11-05 | Eidos Therapeutics Inc. | EIDX | Sinha Uma Chief Scientific Officer | 60,000 | $0 | 0 (Direct) | View |
| 2021-01-11 Exercise | 2021-01-13 4:05 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 3,247 | $7.24 | 50,447 (Direct) | View |
| 2021-01-11 Exercise | 2021-01-13 4:05 pm | N/A 2028-05-06 | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 3,247 | $0 | 50,447 (Direct) | View |
| 2020-12-15 Exercise | 2020-12-16 7:27 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 21,843 | $13.2 | 113,247 (Direct) | View |
| 2020-12-15 Exercise | 2020-12-16 7:27 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 4,451 | $17 | 113,247 (Direct) | View |
| 2020-12-15 Exercise | 2020-12-16 7:27 pm | N/A 2028-06-20 | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 26,294 | $0 | 113,247 (Direct) | View |
| 2020-11-11 Gift | 2020-11-13 5:00 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 1,500 | $0 | 50,621 (Direct) | View |
| 2020-11-09 Exercise | 2020-11-10 4:05 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 1,623 | $7.24 | 27,597 (Direct) | View |
| 2020-11-09 Exercise | 2020-11-10 4:05 pm | N/A 2028-05-06 | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 1,623 | $0 | 27,597 (Direct) | View |
| 2020-11-02 Exercise | 2020-11-03 4:05 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 5,000 | $13.2 | 154,451 (Direct) | View |
| 2020-11-02 Exercise | 2020-11-03 4:05 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 2,500 | $17 | 154,451 (Direct) | View |
| 2020-11-02 Exercise | 2020-11-03 4:05 pm | N/A 2028-11-05 | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 7,500 | $0 | 154,451 (Direct) | View |
| 2020-10-07 Exercise | 2020-10-09 5:23 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 10,199 | $7.24 | 63,639 (Direct) | View |
| 2020-10-07 Exercise | 2020-10-09 5:23 pm | N/A 2028-05-06 | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 10,199 | $0 | 63,639 (Direct) | View |
| 2020-09-10 Exercise | 2020-09-11 4:05 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 2,500 | $17 | 86,951 (Direct) | View |
| 2020-09-10 Exercise | 2020-09-11 4:05 pm | N/A 2028-06-20 | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 2,500 | $0 | 86,951 (Direct) | View |
| 2020-08-06 Option Award | 2020-08-10 7:26 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Hooper Suzanne Sawochka Director | 25,973 | $0 | 25,973 (Direct) | View |
| 2020-08-06 Option Award | 2020-08-10 7:25 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Rohlen Douglas Director | 25,973 | $0 | 25,973 (Direct) | View |
| 2020-08-03 Exercise | 2020-08-05 7:45 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 5,000 | $13.2 | 150,531 (Direct) | View |
| 2020-08-03 Exercise | 2020-08-05 7:45 pm | N/A 2028-11-05 | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 5,000 | $0 | 150,531 (Direct) | View |
| 2020-06-29 Other | 2020-07-01 4:06 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 1,088 | $0 | 397,055 (Indirect) | View |
| 2020-05-31 Option Award | 2020-06-05 4:06 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 376 | $41.57 | 75,531 (Direct) | View |
| 2020-05-31 Option Award | 2020-06-05 4:06 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 444 | $41.57 | 394,879 (Direct) | View |
| 2020-06-01 Gift | 2020-06-05 4:06 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 2,040 | $0 | 394,879 (Indirect) | View |
| 2020-05-31 Option Award | 2020-06-05 4:05 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 444 | $41.57 | 444 (Direct) | View |
| 2020-05-31 Option Award | 2020-06-05 4:05 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Sinha Uma Chief Scientific Officer | 444 | $41.57 | 331,525 (Direct) | View |
| 2020-05-27 Option Award | 2020-05-29 4:08 pm | N/A 2030-05-27 | Eidos Therapeutics Inc. | EIDX | AGUIAR ERIC Director | 21,528 | $0 | 21,528 (Direct) | View |
| 2020-05-27 Option Award | 2020-05-29 4:06 pm | N/A 2030-05-27 | Eidos Therapeutics Inc. | EIDX | Shah Rajeev M. Director | 21,528 | $0 | 21,528 (Direct) | View |
| 2020-05-27 Option Award | 2020-05-29 4:05 pm | N/A 2030-05-27 | Eidos Therapeutics Inc. | EIDX | Satvat Ali J. Director 10% Owner | 21,528 | $0 | 21,528 (Direct) | View |
| 2020-05-27 Option Award | 2020-05-29 4:05 pm | N/A 2030-05-27 | Eidos Therapeutics Inc. | EIDX | Lis William Director | 21,528 | $0 | 21,528 (Direct) | View |
| 2020-05-26 Exercise | 2020-05-28 4:05 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 2,500 | $17 | 94,075 (Direct) | View |
| 2020-05-26 Exercise | 2020-05-28 4:05 pm | N/A 2028-06-20 | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 2,500 | $0 | 94,075 (Direct) | View |
| 2020-05-01 Exercise | 2020-05-05 4:26 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 5,000 | $13.2 | 160,155 (Direct) | View |
| 2020-05-01 Exercise | 2020-05-05 4:26 pm | N/A 2028-11-05 | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 5,000 | $0 | 160,155 (Direct) | View |